超重肥胖體檢人群臨床合并癥研究-國際臨床研究雜志

附屬第一醫(yī)院進行健康體檢的所有體重指數(shù)≥結(jié)果①超重、肥胖總?cè)藬?shù)1660例，其中男性占71.57%，女性28.43%，運用χ2檢驗對兩組不同性別的發(fā)生率進）；）；位的男性發(fā)生肥胖的概率大于其他職業(yè)（P=0.000②運用Pearso兩組低密度脂蛋白、總膽固醇、淀粉樣蛋白比較，差異無統(tǒng)計學意義。結(jié)論肥胖者比超重者并發(fā)更多臨床合并認知、行為、心理等方面對超重肥胖患者進行精細化、個體【關(guān)鍵詞】超重；肥胖；臨床合并癥；多學科協(xié)作【基金項目】寧波市科技計劃項目2021S168HongZhou,XingjunQian*,CaifuHe,KongyangJiangRetrospectiveanalysisofallpeoplewithBMI≥24kg/m2whounderwentphysicalexaminationattheFirstAffilmales(71.57%),weredividedintooverweightandobesegroupsforcomparison,andthecomorbiditiesandcomplicationsbetweenoverweightandobesepeoplewerestudied.Resultsofoverweightandobesity,ofwhich71.57%weremalesand28.43%werefemales.Usingtheχ2testtocomparetheincidenceratesofdifferentgendersinthetwogroups,itwasfoundthatmaleshadthehighestincidencerateofobes(P=0.040);Theagegroupof51-60yearsoldhasthehighestproportionofobesepeople(P=0.000);theprobabilityofobesityamongmenincorporateunitsisgreaterthanthatinotheroccupations(P=0.000);2.ByusingPearsoncorrelationanalysis,itwasfoundthatBMIisrelatedtoage,bloodpressure,Bloodsugar,uricacid,triglyvaluesarepositivelycorrelated.ThehighertheBMI,thegreatertheabnormalityofeachtestvcoefficientisstatisticallysignificant(P<0.05);theχ2testisusedtoanalyzeoverweightandobesepeople, clinicalcomorbiditiesandincidenceratesofcomplicationsbetweenthetw*higherratesoffattyliver,hypertension,hyperglycemia,hyperuricemia,caratesoftriglyceridesandhomocysteinewerehigherthanthoseintheovestatisticallysignificant(P=0.000).Conclusion:Obesepeoplehavemoreclinicalcomplicationsthanoverweigsuchasmetabolicsyndrome,atheroscleroticdiseases,andsubsequentcardiovasVasculardiseases,etc.,candirectlyleadtobesityshouldbeactivelyprevented.Itisrconductrefinedandindividualizedcomprehensiveinterventionforoverweightabehavioral,psychologicalandotheraspectstoachievescientificandef【Keywords】Overweight;Obesity;Clinicalcomorbidities;Multidisciplinarycollabor重和肥胖以體重指數(shù)（BMI）來定義，以24kg/m2≤率大于其他職業(yè)，差異具有非常顯著統(tǒng)計學意義（P）；節(jié)的比率均高于超重組，差異具有統(tǒng)計學意義（P項目n超重（n,%）肥胖（n,%）2值P值性別男503（42.34）685(57.66)女472226（47.88）246(52.12)4.2110.040年齡（歲）<30336194(57.74)142(42.26)31-40490223(45.51)267(54.49)41-50377151(40.05)226(59.95)51-60385128(33.25)257(66.75)>607233(45.83)39(54.167)46.7540.000工作單位事業(yè)714386(54.06)328(45.94)企業(yè)45163(13.97)388(86.03)無業(yè)495280(56.57)215(43.43)226.2180.000項目rP年齡0.0920.000血壓0.2700.000血糖0.0560.022尿酸0.2380.000甘油三酯0.1750.000低密度脂蛋白0.0440.075總膽固醇0.0240.337淀粉樣蛋白-0.0180.472同型半胱氨酸0.0850.001項目n超重（n,%）肥胖（n,%）2值P值脂肪肝無脂肪肝841390(46.37)451(53.56)脂肪肝血壓819339(41.39)480(58.61)4.1800.041血壓正常952518(54.41)434(45.59)血壓偏高甲狀腺結(jié)節(jié)708211(29.80)497(70.20)99.8410.000無664280(42.17)384(57.83)有肺結(jié)節(jié)996449(45.08)547(54.92)1.3710.242無663269(40.57)394(59.43)有997460(46.14)537(53.86)5.0070.025膽囊息肉結(jié)石無1240529(42.66)711(57.34)有血糖420200(47.62)220(52.38)3.1310.077血糖正常1637726(44.35)911(55.65)血糖偏高尿酸233(13.04)20(86.96)9.0250.003尿酸正常542(48.31)580(51.70)高尿酸血癥頸動脈超聲538159(29.55)379(70.45)52.4170.000n單位的男性發(fā)生肥胖的概率大于其他職業(yè)；2.運用科學有效減重目的，已形成了較為成熟有效的管理模[1]中國超重肥胖醫(yī)學營養(yǎng)治療專家共識編寫委員會.中國尿病雜志,2016,8(9):525—540.Obesity-ProgressandFut2020,383(23):2197-2200.圍與H型高血壓患病關(guān)系[J].中國公共衛(wèi)生,2020,[4]世界衛(wèi)生組織.關(guān)于肥胖的十個事實,[EB/OL].(2017-11)[2021-03-15].https://wwYSA,etal.ObesityinAsia–isitdi[6]王友發(fā),孫明曉,楊月欣,等.中國肥胖預防和控制藍皮書[7]國家衛(wèi)生健康委員會.《中國居民營養(yǎng)與慢性病狀況報告(2020）》發(fā)布會[EB/OL].（2020-12-23）[2021-03-15].http://www//xw42311/44583/index.htm#1.[8]李曉燕,姜勇,胡楠.2010年我國成年人超重及肥胖流行特征[J].中華預防醫(yī)學雜志2012,46(8):683-686.胖患病率及影響因素分析[J].中國急救醫(yī)學,2018,38(10):[10]賈鑫,叢革新,劉輝,等.2017年中國調(diào)查分析[J].中國健康教育2022,3流行趨勢的性別差異[J].中國衛(wèi)生統(tǒng)計,2021,38(4):（36）9:779-784.[14]張彥亭,高從,馬立新.石家莊市≥18歲居民超重與肥胖現(xiàn)狀及其影響因素分析[J].中國公共衛(wèi)生.2015,7(31):snackingbehaviorsamongchildrenandadolesceChina.[J].TheJournalofadolescenthealth:opublicationoftheSocietyforAdolescent2010(4):339-45.andobesityriskindependentlyofwalkingtpeoplefromSpain[J].Maturitas,2012,73(4):337-34[20]張宏,雒瑢,田鳳石.性別對超重人群皮下脂肪脂聯(lián)素mRNA表達的影響[J].中國老年學雜志,2010,9(30):[22]RothbergAE,McewenLN,KraftsonAT,etal.Impactofweightlossonwaistcircumferenceandthecomponentsofthemetabolicsyndrome[J].2017,5(1):e000341.doi:10.1136/bmjdrc-20modificationapproachesforthetreatmentadults[J].AmPsychol,20fProgrammeforOver